C000218221 Performance — JNL/Newton Equity Income Fund, Class I
Data updated: 2026-08-26
C000218221 returned +13.83% year to date and +25.48% over one year to Jun 2026. Annualised returns are +19.44% over 3 years and +15.10% over 5 years. The fund beat its US Large Value category average: $100 invested three years ago grew to $170, against $158 for the category, and to $125 over one year, against $121. Volatility over the past three years was 11.16% a year. In the 12 months to Jun 2026 the fund took in a net $227.9M, and assets reached $4.43B.
C000218221 Growth of $100
What $100 invested in JNL/Newton Equity Income Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Value category average over the same months.
| Period | C000218221 | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $125 | $121 |
| 3 years (Jul 2023 – Jun 2026) | $170 | $158 |
| 5 years (Jul 2021 – Jun 2026) | $202 | $165 |
| Since data start (Apr 2020 – Jun 2026) | $365 | $268 |
C000218221 Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +13.83% |
| 1 year | +25.48% |
| 3 years (annualised) | +19.44% |
| 5 years (annualised) | +15.10% |
C000218221 Annual Returns
Calendar-year total returns of JNL/Newton Equity Income Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +13.83% |
| 2025 | +19.32% |
| 2024 | +17.45% |
| 2023 | +10.67% |
| 2022 | +4.11% |
| 2021 | +33.18% |
| 2020 (Apr–Dec) | +49.29% |
C000218221 Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.9% | +3.2% | −4.1% | +6.2% | +1.8% | +2.5% | — | — | — | — | — | — |
| 2025 | +4.9% | +1.3% | −2.8% | −3.6% | +4.4% | +4.2% | +0.6% | +4.0% | +0.3% | +0.3% | +2.7% | +1.9% |
| 2024 | +0.8% | +3.3% | +5.1% | −3.8% | +3.8% | −1.3% | +4.2% | +3.5% | +2.1% | +0.3% | +5.9% | −6.9% |
| 2023 | +4.0% | −2.7% | −1.2% | +1.8% | −4.7% | +6.9% | +3.9% | −0.8% | −2.3% | −2.3% | +5.4% | +3.0% |
| 2022 | −0.8% | +1.6% | +3.5% | −5.7% | +3.9% | −8.3% | +5.6% | −1.4% | −7.4% | +12.6% | +5.8% | −3.3% |
| 2021 | +0.4% | +7.8% | +5.0% | +5.1% | +2.7% | −1.2% | +0.7% | +3.1% | −3.1% | +6.2% | −3.0% | +6.1% |
| 2020 | — | — | — | +11.7% | +4.2% | +1.0% | +3.5% | +4.7% | −3.0% | +0.6% | +15.0% | +4.4% |
C000218221 Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 11.16%
- 3-year Sharpe ratio: 1.34 (vs 4.5% risk-free rate)
- Best month: +6.15% (Apr 2026)
- Worst month: −6.86% (Dec 2024)
C000218221 Fund Flows
Monthly money in and out of JNL/Newton Equity Income Fund, from SEC Form N-PORT.
- 12-month net flow: $227.9M
- 12-month gross sales (incl. reinvestments): $1.3B
- Sales ÷ redemptions: 1.21×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $123.0M | $103.0M | $20.0M |
| May 2026 | $84.6M | $104.8M | −$20.2M |
| Apr 2026 | $88.3M | $79.8M | $8.5M |
| Mar 2026 | $114.5M | $95.1M | $19.4M |
| Feb 2026 | $110.2M | $76.1M | $34.1M |
| Jan 2026 | $92.2M | $78.1M | $14.2M |
| Dec 2025 | $230.6M | $90.5M | $140.1M |
| Nov 2025 | $46.3M | $60.6M | −$14.4M |
| Oct 2025 | $77.1M | $83.3M | −$6.3M |
| Sep 2025 | $95.2M | $127.4M | −$32.2M |
| Aug 2025 | $74.1M | $72.4M | $1.7M |
| Jul 2025 | $153.6M | $90.7M | $62.9M |
C000218221 Assets Under Management
Net assets of JNL/Newton Equity Income Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $4.43B |
| 2026-03-31 | $4.00B |
| 2025-12-31 | $3.83B |
| 2025-09-30 | $3.53B |
| 2025-06-30 | $3.33B |
| 2025-03-31 | $3.13B |
| 2024-12-31 | $2.72B |
| 2024-09-30 | $2.59B |
| 2024-06-30 | $2.31B |
| 2024-03-31 | $2.30B |
| 2023-12-31 | $1.90B |
| 2023-09-30 | $1.79B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.